Skip to main content
. 2021 May 16:zxab202. doi: 10.1093/ajhp/zxab202

Table 1.

Baseline Characteristics and Laboratory Values in Patient Cohort (n = 86)

Median (IQR)a
Age, y 61 (48.5-74.5)
Male, No. (%) 56 (65)
Weight, kg 82 (74.0-102.6)
Height, cm 167.6 (160.0-175.0)
Diabetes, No. (%) 34 (39)
Hyperlipidemia, No. (%) 40 (46)
Immunosuppressed, No. (%) 9 (10)
Chronic pain, No. (%) 8 (9)
Substance use disorder, No. (%) 5 (6)
Laboratory values
 Creatinine, mg/dL 168 (114.5-260.0)
 AST, U/L 59.50 (44.5-77.25)
 ALT, U/L 38.50 (30.25-41.75)
 ALP, U/L 69.50 (51.25-81.50)
 Total bilirubin, mg/dL 0.50 (0.20-0.50)
 TG, mg/dL 168 (114.5-260.0)
 ESR, mm/h 48 (28.0-68.0)
 CRP, mg/L 147.9 (75.5-226.2)
 Ferritin, μg/L 739 (405.0-1,358.0)
 D-dimer, nL/mL 1,043.5 (794.0-1,776.0)
 LDH, U/L 395 (319.5-539.0)
 CK, U/L 152 (86.0-417.0)
Pao2:Fio2 193.7 (149.0-267.3)

Abbreviations: ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; IQR, interquartile range; LDH, lactate dehydrogenase; Pao2, arterial partial pressure of oxygen; Fio2, fraction of inspired oxygen; TG, triglycerides.

aUnless otherwise indicated.